Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Avantogen Oncology, Inc.    AVTO

Delayed Quote. Delayed  - 09/25 09:43:10 pm
0.012 USD   +81.82%
 SummaryQuotesChartsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
07/17/2017 07/25/2017 07/26/2017 09/19/2017 09/25/2017 Date
0.02(c) 0.01(c) 0.012(c) 0.0066(c) 0.012(c) Last
1 500 50 000 60 000 1 500 16 000 Volume
+5.26% -50.00% +20.00% -45.00% +81.82% Change
More quotes
Company
Avantogen Oncology, Inc. operates as a development stage company.It is engaged in the acquisition and development of novel compounds to treat patients with various types of cancer.The company was founded in 1986 and is headquartered in Los Angeles, CA. 
More about the company
Latest news on AVANTOGEN ONCOLOGY, INC.

- No features available -

More news
Sector news : Biotechnology & Medical Research - NEC
08:48aDJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
10/17 Regeneron-Sanofi drug succeeds mid-stage study
10/17DJJOHNSON & JOHNSON : Outlook Buoyed by Drug Unit -- Update
10/17DJJOHNSON & JOHNSON : Raises Guidance on Earnings Beat
10/05DJAppeals Court Rules Against Amgen in Patent Case -- Update
More sector news : Biotechnology & Medical Research - NEC
Chart AVANTOGEN ONCOLOGY, INC.
Duration : Period :
Avantogen Oncology, Inc. Technical Analysis Chart | AVTO | US05350Y1001 | 4-Traders
Managers
NameTitle
William J. Ardrey Chairman, President & Chief Executive Officer
Sector and Competitors
1st jan.Capitalization (M$)
AVANTOGEN ONCOLOGY, INC.140.00%0
INCYTE CORPORATION14.00%24 360
QUINTILES IMS HOLDINGS INC31.30%21 440
CELLTRION, INC.--.--%20 806
LONZA GROUP64.29%19 850
ALNYLAM PHARMACEUTICALS, INC.228.53%10 889